Vortex Biosciences Alternatives & Competitors

12 companies similar to Vortex Biosciences

Cellsway

Liquid biopsy for cancer monitoring through isolation and counting Circulating Tumor Cells...

5 $1.45M

Ankara, United Kingdom

Biotechnology Health Care

Capio Biosciences

4 Series A $2.90M

Madison, United States

Biotechnology Health Care

On-Q-ity

Empowering physicians with advanced tools to improve cancer treatment decisions and enhanc...

Series B $31.00M

Biotechnology Health Care

ANGLE

The leading experts in cancer cell capture and analysis from liquid biopsies

165 Post-IPO Equity $29.68M

United Kingdom

Biotechnology Health Care +1

Rival Readout

Competing with Vortex Biosciences? We do this properly.

10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.

Book a 7-day Readout

RareCyte, Inc.

A one-stop resource for Spatial Biology and Liquid Biopsy solutions.

65 Venture round $96.00M

Seattle, United States

Biotechnology Health Care +1

Surface Oncology Inc.

#lifeunderthesurface #BBJBestPlacesToWork2023,2022,2021 #BostonGlobeTopPlacesToWork2023,2...

14 Post-IPO Equity $88.90M

Cambridge, United States

Biotechnology Health Care +1

Sensei Bio

We follow the immune system’s teachings to discover new treatments that inspire the body t...

32 Series B $58.50M

Rockville, United States

Biotechnology Health Care +2

LungLife AI

LungLife AI is transforming lung cancer diagnosis and management through AI-enabled analys...

16 Post-IPO Equity $56.24M

Thousand Oaks, United Sta...

AI Biotechnology +2

GILUPI GmbH

Advancing diagnostic procedures for precision medicine

8 Acquired $3.60M

Potsdam, Germany

Biotechnology Health Care +1

Merus N.V.

Merus was acquired by Genmab. To see what’s new, visit Genmab.

177 Post-IPO Equity $1.04B

Utrecht, The Netherlands

Biotechnology Health Care +1

Amadix

Early cancer detection in blood

43 Grant $4.55M

Valladolid, Spain

Biopharma Biotechnology +3

Exai Bio

Delivering next-generation liquid biopsy platform for the earliest detection and most accu...

22 $138.96M

Palo Alto, United States

Biotechnology Health Care

About Vortex Biosciences

Vortex Biosciences is a biotechnology startup founded in 2012, headquartered in the United States. The company specializes in developing innovative Circulating Tumor Cell (CTC) capture technology. Their flagship product, the VTX-1 Liquid Biopsy System, automates the isolation and collection of CTCs from blood samples,...

Business keywords

Circulating Tumor Cells, Cancer Biology, Microfluidic Engineering, Informatics, Liquid Biopsy, Oncology Diagnostics, Cancer Biomarkers, Cancer Research, Cancer Diagnosis, Therapeutic Decisions, Clinical Research, Drug Targets, Diagnostic Tests, CTC Capture Technology

Frequently Asked Questions

Companies similar to Vortex Biosciences include Cellsway, Capio Biosciences, On-Q-ity, ANGLE, RareCyte, Inc.. They work in Biotechnology and Health Care and share Vortex Biosciences's focus on liquid biopsy, circulating tumor cells and cancer research.

Bounce Watch lists 12 companies that share Vortex Biosciences's industries and are closest to it in business tags, services, target customers, business model and size.

From the desk

Mapping a market? Start with a Rival Readout.

In 7 business days we read 10 rivals around Vortex Biosciences: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.

Book a 7-day Readout Get a free snapshot

Explore Related

Vortex Biosciences Profile Cellsway Alternatives Capio Biosciences Alternatives On-Q-ity Alternatives All Companies All Signals Trend Reports

Compiled from the BounceWatch company index. We last looked at Vortex Biosciences on 11 Sep 2024. The 12 companies listed here were last checked between 11 Sep 2024 and 2 Sep 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.